710 related articles for article (PubMed ID: 2189490)
21. Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis.
Sassa H; Sone T; Tsuboi H; Kondo J; Yabashi T
Jpn Circ J; 1996 Apr; 60(4):201-6. PubMed ID: 8726168
[TBL] [Abstract][Full Text] [Related]
22. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
23. Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Yamashita T; Nomoto K; Tahara M; Atsuchi Y
Int J Cardiol; 1994 Dec; 47(1 Suppl):S7-12. PubMed ID: 7737755
[TBL] [Abstract][Full Text] [Related]
24. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
25. Procoagulant activity in patients with isolated severe head trauma.
Scherer RU; Spangenberg P
Crit Care Med; 1998 Jan; 26(1):149-56. PubMed ID: 9428558
[TBL] [Abstract][Full Text] [Related]
26. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
27. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
28. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
29. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
30. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
[TBL] [Abstract][Full Text] [Related]
32. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
33. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancer.
Mitter CG; Zielinski CC
J Cancer Res Clin Oncol; 1991; 117(3):259-62. PubMed ID: 2033094
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
36. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.
Tanaka M; Suzuki A
Thromb Res; 1994 Nov; 76(3):289-98. PubMed ID: 7863479
[TBL] [Abstract][Full Text] [Related]
37. Hypercoagulability and DIC in high-risk infants.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
[TBL] [Abstract][Full Text] [Related]
38. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
39. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma.
García-Avello A; Lorente JA; Cesar-Perez J; García-Frade LJ; Alvarado R; Arévalo JM; Navarro JL; Esteban A
Thromb Res; 1998 Jan; 89(2):59-64. PubMed ID: 9630308
[TBL] [Abstract][Full Text] [Related]
40. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications.
Olson JD
Adv Clin Chem; 2015; 69():1-46. PubMed ID: 25934358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]